December 8, 2025

argenx SE (ARGX) Stock Analysis: Strong Growth Potential with Revenue Surge and Analyst Confidence

argenx SE (ARGX), the Netherlands-based biotechnology firm, is turning heads in the healthcare sector with its formidable market presence and innovative pipeline. With a market capitalization of $56.12 billion, argenx..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Promising Biotech with a 97.93% Upside Potential

Vaxcyte, Inc. (NASDAQ: PCVX), a clinical-stage vaccine innovation company, is gaining significant attention within the biotechnology sector. With its focus on developing next-generation conjugate and novel protein vaccines, the company..

Corcept Therapeutics (CORT) Stock Analysis: Discovering a 57% Upside Potential in the Biotech Sector

In the dynamic world of biotechnology, Corcept Therapeutics Incorporated (NASDAQ: CORT) presents a compelling opportunity for investors seeking high-growth potential. With a market capitalization of $9.07 billion, this Redwood City,..

Verona Pharma plc (VRNA) Stock Analysis: Exploring the $9.09 Billion Biotech Leader’s Growth Trajectory

Verona Pharma plc (VRNA), a prominent player in the biotechnology sector, has captured the attention of investors with its strong market presence and promising therapeutic developments. Operating out of London,..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating the 2.84% Upside in Healthcare Investment

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a leading name in the healthcare sector, presents a blend of stability and modest growth potential that could appeal to investors seeking exposure to..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Promising 22.86% Upside Beckons Investors

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a leading player in the biotechnology sector, offers a compelling investment opportunity with a potential upside of 22.86%, according to analyst forecasts. Based in Dublin,..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Navigating Biotech Growth with a 4.64% Upside and Strong Buy Ratings

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands as a compelling entity in the biotechnology sector, captivating investors with its innovative RNA-targeted medicines. With a market capitalization of $13.23 billion, Ionis is..

McKesson Corporation (MCK) Stock Analysis: A Healthcare Giant with a 15.6% Potential Upside

McKesson Corporation (NYSE: MCK), with its $100.58 billion market capitalization, stands as a formidable player in the healthcare sector, specifically in the medical distribution industry. As a U.S.-based entity, McKesson..

Insulet Corporation (PODD): Analyst Ratings Signal 24% Upside Potential for this Healthcare Innovator

Insulet Corporation (NASDAQ: PODD), a leading player in the medical devices sector, is carving out a significant niche in the healthcare industry with its innovative insulin delivery systems. With a..

Legend Biotech Corporation (LEGN) Stock Analysis: Unpacking the 166% Potential Upside in Revolutionary CAR-T Therapies

Investors eyeing the healthcare sector may want to take a closer look at Legend Biotech Corporation (NASDAQ: LEGN), a promising player in the biotechnology industry that is making significant strides..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a 9.27% Upside Potential Amid Robust Growth

Thermo Fisher Scientific Inc (NYSE: TMO), a leading player in the Healthcare sector and a stalwart in the Diagnostics & Research industry, continues to capture investor interest with its substantial..

Chemed Corp (CHE) Stock Analysis: A 36% Upside Potential Amid Strong Analyst Ratings

Investors searching for opportunities in the healthcare sector might find Chemed Corp (NYSE: CHE) an intriguing prospect. Operating primarily in the United States, Chemed provides hospice and palliative care services,..

Grifols, S.A. (GRFS) Stock Analysis: Unpacking the 27% Upside Potential for Savvy Investors

Grifols, S.A. (NASDAQ: GRFS), a stalwart in the healthcare sector and a pioneer in plasma-derived therapies, presents an intriguing investment opportunity with a potential upside of 27.12%, according to the..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Healthcare Giant with 9.16% Upside Potential

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a stalwart in the healthcare sector, specifically in the medical devices industry, stands at a pivotal juncture for investors. With a current market capitalization..

Agilent Technologies, Inc. (A) Stock Analysis: A Healthcare Play with 16% Potential Upside

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, particularly in the diagnostics and research industry, offers a compelling case for investors seeking exposure to cutting-edge scientific..

Glaukos Corporation (GKOS) Investor Outlook: A High-Flying Stock with 11% Upside Potential

For investors keen on the burgeoning healthcare sector, Glaukos Corporation (NYSE: GKOS) represents a compelling opportunity. Specializing in ophthalmic pharmaceutical and medical technology, Glaukos is at the forefront of developing..

Waystar Holding Corp. (WAY) Stock Analysis: A 43% Potential Upside Amid Strong Buy Ratings

Investors seeking opportunities in the healthcare technology sector should give Waystar Holding Corp. (NASDAQ: WAY) their attention. Specializing in cloud-based software solutions for healthcare payments, Waystar is strategically positioned in..

Globus Medical, Inc. (GMED) Stock Analysis: A Compelling Play in the Healthcare Sector Amidst Strong Revenue Growth

Globus Medical, Inc. (NYSE: GMED), a prominent player in the healthcare sector, has been making significant strides with its innovative medical devices aimed at addressing musculoskeletal disorders. With a market..

TG Therapeutics, Inc. (TGTX) Stock Analysis: Unveiling a 44% Upside Potential Amidst Robust Revenue Growth

TG Therapeutics, Inc. (NASDAQ: TGTX), a biopharmaceutical firm rooted in the healthcare sector, is capturing the attention of investors with its promising pipeline and significant growth metrics. Specializing in treatments..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 10.93% Upside Potential Amidst Strong Cash Flow and Dividend Yield

Viatris Inc. (VTRS), a prominent player in the healthcare sector, stands out in the drug manufacturing industry with its extensive range of products, including generic and specialty drugs, as well..

Search

Funds

December 8, 2025

Search

Funds

December 8, 2025

FTSE 100

Funds